Brian M Culley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian M Culley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian M Culley. Brian M Culley is President and CEO in BIOTIME INC ($BTX) and Chief Executive Officer in Artemis Therapeutics, Inc. ($INKS) and CEO and Director in Mast Therapeutics, Inc. ($MSTX).
Latest Insider Trading Transactions of Brian M Culley
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, INKS, BTX, SVRA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 77,250 | |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 2.35 | 5,343 | 12,556 | 195,709 | 201.1 K to 195.7 K (-2.66 %) |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 2.35 | 15,450 | 36,308 | 201,052 | 185.6 K to 201.1 K (+8.32 %) |
Mar 17 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | A | 2.43 | 1,165,100 | 2,831,193 | 1,165,100 | |
Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 92,700 | |
Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 1.76 | 5,343 | 9,404 | 185,602 | 190.9 K to 185.6 K (-2.80 %) |
Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 1.76 | 15,450 | 27,192 | 190,945 | 175.5 K to 190.9 K (+8.80 %) |
Jul 02 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 123,600 | |
Jul 02 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.87 | 5,343 | 4,648 | 165,388 | 170.7 K to 165.4 K (-3.13 %) |
Jul 02 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.87 | 15,450 | 13,442 | 170,731 | 155.3 K to 170.7 K (+9.95 %) |
Mar 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 139,050 | |
Mar 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.83 | 5,343 | 4,425 | 155,281 | 160.6 K to 155.3 K (-3.33 %) |
Mar 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.83 | 15,450 | 12,794 | 160,624 | 145.2 K to 160.6 K (+10.64 %) |
Mar 19 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | A | 0.69 | 1,233,300 | 853,320 | 1,233,300 | |
Dec 31 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 154,500 | |
Dec 31 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.89 | 5,343 | 4,755 | 145,174 | 150.5 K to 145.2 K (-3.55 %) |
Dec 31 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.00 | 15,450 | 0 | 150,517 | 135.1 K to 150.5 K (+11.44 %) |
Oct 01 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 169,950 | |
Oct 01 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.98 | 5,343 | 5,236 | 135,067 | 140.4 K to 135.1 K (-3.81 %) |
Oct 01 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.00 | 15,450 | 0 | 140,410 | 125 K to 140.4 K (+12.36 %) |
Sep 19 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 61,800 | 0 | 185,400 | |
Sep 19 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 1.00 | 21,371 | 21,371 | 124,960 | 146.3 K to 125 K (-14.60 %) |
Sep 19 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.00 | 61,800 | 0 | 146,331 | 84.5 K to 146.3 K (+73.11 %) |
Aug 15 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | P | 1.01 | 10,000 | 10,100 | 84,531 | 74.5 K to 84.5 K (+13.42 %) |
Jan 03 2019 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
Jan 03 2019 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Payment of Exercise | F | 0.91 | 40,880 | 37,323 | 59,120 | 100 K to 59.1 K (-40.88 %) |
Jan 03 2019 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 2.31 | 1,500,000 | 3,465,000 | 1,500,000 | |
Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 2.31 | 1,500,000 | 3,465,000 | 1,500,000 | |
Mar 19 2018 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 1.30 | 48,528 | 63,086 | 48,528 | |
Oct 25 2017 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Option Exercise | P | 2.00 | 12,500 | 25,000 | 12,500 | |
Oct 25 2017 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Buy | P | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Sep 05 2017 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 1.30 | 242,640 | 315,432 | 242,640 | |
Jan 23 2017 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.00 | 2,368,194 | 0 | 2,368,194 | |
Jan 06 2016 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.42 | 1,227,100 | 515,382 | 1,227,100 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.50 | 888,900 | 444,450 | 888,900 |
Page: 1